Image

Error-enhanced Learning & Recovery in 2 & 3 Dimensions

Error-enhanced Learning & Recovery in 2 & 3 Dimensions

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is being done to see how errors lead to improvement. Specifically, we are evaluating the errors stroke participants make during an upper extremity exercise program when reaching for a target using their affected arm. Once we understand the participant's reaching errors, we plan to create a customized reaching exercise according to the individual's specific error tendencies which will lead to better performance on movement ability after training.

Description

The neuroplasticity of motor re-learning is a key pathway for recovery in neurorehabilitation. One critical challenge to devising treatment plans for motor recovery is the wide variation that exists between individuals, across movement repetitions, and even within movements. Development of a learning model that looks at these factors would better relate diagnoses to treatments, providing personalization and efficiency to therapy. This proposal aims to advance rehabilitation by building a modeling framework that explores the trends and exploits a fundamental learning process - error. Our goal is to preliminarily test the direct effect of this new treatment in preparation for the randomized controlled study to come. Understanding how error leads to better performance will help us program future devices for therapy for optimal outcomes.

We are using research lab equipment at the Shirley Ryan AbilityLab (SRALab) Hospital's Robotics group. The equipment will be used to implement the reaching exercises and measure participant movement. The equipment includes:

  1. Barret b.u.r.t. arm robot with Teneo forearm attachment
  2. LookingGlass virtual reality display system
  3. Garmin Venu Sq fitness tracking wristwatch

Study Outline:

Week 1, Visit 1: Consent, In-Person Screening, and Baseline Evaluations Participants will sign a consent form. Then, they will undergo a screening process to check if they meet all the eligibility requirements. Participants that pass the in-person screening and agree to continue with the study will complete baseline evaluations which will consistent of upper extremity outcome measures, and a preliminary reaching experiment on the b.u.r.t. robotic arm.

Weeks 2-3, Visits 2-7: Treatment Visits In the following two weeks, participants will come to the lab three times a week. They will use the robotic arm, and complete several rounds of reaching exercises while looking in the virtual reality display system. Depending on the treatment visit, participants will either take home a fitness tracker, or be asked to return it.

Week 4, Visit 8: Post-Evaluations About a week after the treatment sessions, participants will return to the lab and complete the same evaluations they completed during visit 1 to see if there is any change.

Weeks 5-8: There will be no lab visits during this time.

Week 9, Visit 9: About 5-6 weeks after the treatment visits, participants will come back for follow-up evaluations. These will be the same outcome measures completed during the baseline and post-evaluation sessions.

Eligibility

Inclusion Criteria:

  1. 18 years of age or older
  2. Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
  3. Hemiparesis
  4. Some degree of both shoulder and elbow movement capability

Exclusion Criteria:

  1. Bilateral paresis
  2. Severe tactile deficits using the Two-Point Discrimination Test (participant must detect<11mm)
  3. Severe proprioceptive deficits
  4. Severe spasticity (Modified Ashworth >3) preventing movement
  5. Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
  6. Visual deficits, and hemispatial neglect that would prevent the subjects from seeing the targets.
  7. Inability to provide an informed consent
  8. severe current medical problems
  9. diffuse/multiple lesion sites or multiple stroke events
  10. Inability to attain and maintain testing positions
  11. Botox injection to the affected upper extremity within the previous 4 months
  12. Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
  13. Participation in previous, similar robotics intervention study
  14. Other neurological issues

None of the following special populations will be included in this research study:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

Study details
    Stroke
    Cerebral Vascular Accident (CVA)/Stroke

NCT05180786

Shirley Ryan AbilityLab

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.